Mcdaniel Terry & CO Becton Dickinson & CO Transaction History

Mcdaniel Terry & CO

$1.19 Billion
Q3 2024

A detailed history of Mcdaniel Terry & CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, Mcdaniel Terry & CO holds 85,383 shares of BDX stock, worth $19.4 Million. This represents 1.72% of its overall portfolio holdings.

Number of Shares

85,383

Previous 82,646 3.31%

Holding current value

$19.4 Million

Previous $19.3 Million 6.58%

% of portfolio

1.72%

Previous 1.69%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$221.47 - $242.41 $606,163 - $663,476	2,737 Added 3.31%	85,383 $20.6 Million
Q2 2024 Aug 05, 2024	BUY	$225.07 - $246.17 $37,811 - $41,356	168 Added 0.2%	82,646 $19.3 Million
Q1 2024 Apr 29, 2024	SELL	$233.45 - $247.73 $356,478 - $378,283	-1,527 Reduced 1.82%	82,478 $20.4 Million
Q4 2023 Jan 24, 2024	BUY	$232.24 - $267.23 $51,789 - $59,592	223 Added 0.27%	84,005 $20.5 Million
Q3 2023 Oct 23, 2023	BUY	$254.9 - $283.59 $214,880 - $239,066	843 Added 1.02%	83,782 $21.7 Million
Q2 2023 Jul 21, 2023	SELL	$238.39 - $265.32 $121,817 - $135,578	-511 Reduced 0.61%	82,939 $21.9 Million
Q1 2023 May 05, 2023	BUY	$229.71 - $259.35 $73,277 - $82,732	319 Added 0.38%	83,450 $20.7 Million
Q4 2022 Jan 23, 2023	BUY	$218.29 - $256.91 $23,793 - $28,003	109 Added 0.13%	83,131 $21.1 Million
Q3 2022 Oct 06, 2022	BUY	$51.03 - $264.23 $30,771 - $159,330	603 Added 0.73%	83,022 $18.5 Million
Q2 2022 Jul 28, 2022	BUY	$234.74 - $275.42 $320,420 - $375,948	1,365 Added 1.68%	82,419 $20.3 Million
Q1 2022 Apr 27, 2022	SELL	$243.64 - $270.48 $5,116 - $5,680	-21 Reduced 0.03%	81,054 $21.6 Million
Q4 2021 Jan 20, 2022	BUY	$230.08 - $250.94 $578,651 - $631,114	2,515 Added 3.2%	81,075 $20.4 Million
Q3 2021 Dec 06, 2021	BUY	$232.72 - $256.47 $571,560 - $629,890	2,456 Added 3.23%	78,560 $19.3 Million
Q2 2021 Aug 11, 2021	BUY	$232.65 - $254.58 $391,549 - $428,458	1,683 Added 2.26%	76,104 $18.5 Million
Q1 2021 May 17, 2021	BUY	$232.09 - $256.88 $184,047 - $203,705	793 Added 1.08%	74,421 $18.1 Million
Q4 2020 Feb 12, 2021	BUY	$221.92 - $245.94 $350,189 - $388,093	1,578 Added 2.19%	73,628 $18.4 Million
Q3 2020 Nov 09, 2020	BUY	$215.77 - $276.76 $202,608 - $259,877	939 Added 1.32%	72,050 $16.8 Million
Q2 2020 Aug 13, 2020	SELL	$219.9 - $263.41 $609,342 - $729,909	-2,771 Reduced 3.75%	71,111 $17 Million
Q1 2020 May 08, 2020	BUY	$195.69 - $279.01 $598,028 - $852,654	3,056 Added 4.31%	73,882 $17 Million
Q4 2019 Feb 03, 2020	SELL	$236.45 - $266.82 $218,006 - $246,008	-922 Reduced 1.29%	70,826 $19.3 Million
Q3 2019 Nov 07, 2019	SELL	$230.58 - $256.08 $210,750 - $234,057	-914 Reduced 1.26%	71,748 $18.1 Million
Q2 2019 Aug 12, 2019	BUY	$217.4 - $246.08 $217,182 - $245,833	999 Added 1.39%	72,662 $18.3 Million
Q1 2019 May 09, 2019	SELL	$206.05 - $248.17 $62,639 - $75,443	-304 Reduced 0.42%	71,663 $0
Q4 2018 Feb 07, 2019	SELL	$204.73 - $257.93 $20,677 - $26,050	-101 Reduced 0.14%	71,967 $16.2 Million
Q3 2018 Nov 13, 2018	SELL	$233.07 - $256.0 $234,468 - $257,536	-1,006 Reduced 1.38%	72,068 $18.8 Million
Q2 2018 Aug 13, 2018	BUY	$208.1 - $233.85 $281,351 - $316,165	1,352 Added 1.89%	73,074 $17.5 Million
Q1 2018 May 11, 2018	SELL	$205.46 - $240.27 $26,093 - $30,514	-127 Reduced 0.18%	71,722 $15.5 Million
Q4 2017 Feb 09, 2018	BUY	$189.0 - $222.64 $9,261 - $10,909	49 Added 0.07%	71,849 $15.4 Million
Q3 2017 Nov 13, 2017	BUY	$186.89 - $198.9 $2.18 Million - $2.32 Million	11,643 Added 19.35%	71,800 $14.1 Million
Q2 2017 Aug 10, 2017	BUY	N/A	60,157	60,157 $11.7 Million

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.7B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcdaniel Terry & CO, based on Form 13F filings with the SEC.

News

Stay updated on Mcdaniel Terry & CO with notifications on news.

Account

Mcdaniel Terry & CO Becton Dickinson & CO Transaction History